Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free
Close

Sanofi SA (SASY)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
78.540 -0.520    -0.66%
23/09 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  FR0000120578 
WKN:  920657
  • Volume: 3,627
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 77.620 - 79.760
Sanofi 78.540 -0.520 -0.66%

SASY Dividends

 
Get information about Sanofi dividends and ex-dividend dates. You can find more details by going to one of the sections under this page such as ex-date, dividend and payment date.
InvestingPro Dividend Insights
Ex-Dividend Date Dividend Type Payment Date Yield
May 06, 2022 3.33 May 10, 2022 3.35%
May 06, 2022 May 10, 2022 -
May 05, 2021 3.2 May 07, 2021 3.69%
May 04, 2020 3.15 May 06, 2020 3.53%
May 09, 2019 3.07 May 13, 2019 3.94%
May 11, 2018 3.03 May 15, 2018 4.59%
May 16, 2017 2.96 May 18, 2017 3.20%
Legend
Monthly
Quarterly
Semi-Annual
Annual
Trailing Twelve Months
Other
Interim
Final
Bonus
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced dividend insights and history for in-depth analysis of historical dividend payouts and performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SASY Comments

Write your thoughts about Sanofi SA
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
alex inve
alexinve Sep 20, 2022 11:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
And after the downside due to GSK vaccine problem back in the beginning of August, here we have again Sanofi below 80€. Will it try to look for 75€? Will the removal of masks in public transport increase/decrease its share price? Will the supply chain crisis negatively affect the stock dragging it further down to 67€ covid level (around 2012 onwards lows?) That last question would mean PER decreasing to 15 level, while GSK PER is 14.80 and ROCHE is 21.19.
gino freeboter
gino freeboter Apr 06, 2022 6:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what Is going on?
Fabio Ravanelli
Fabio Ravanelli Apr 06, 2022 6:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
they have been sied. They used to produce a OTC medicine that may cause cancer.
Chemsedine Bendaci
Chemsedine Bendaci Feb 07, 2022 4:03AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
huge results coming
Chemsedine Bendaci
Chemsedine Bendaci Jan 12, 2022 8:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
target price 110€ according to investir
Marek Qu
Marek Qu Sep 07, 2021 5:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
SASY is creating separate company Opella World Wide to separate CHC/OTC business. With standard business they may look for a merger. I think we could expect a merger with GSK.
Alessandro To
Alessandro To Aug 26, 2021 12:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Indietro tutta con problemi legali!!!???
Ali Gaye
Ali Gaye Aug 21, 2021 7:08AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sanofi
Alessandro To
Alessandro To Aug 20, 2021 1:01AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Vola occhio!!
Claudio Morelli
Claudio Morelli Mar 04, 2021 5:50AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sanofi Stuck as it’s not involved in the vaccine process; this is so disturbing
Fouad Abddaim
Fouad Abddaim Feb 05, 2021 2:58AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Very good earnings, to the moonnnnnn
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email